Oramed Pharmaceuticals (ORMP) Deferred Taxes (2017 - 2026)

Oramed Pharmaceuticals' (ORMP) quarterly Deferred Taxes came in at -$9.8 million in Q1 2026, down 98460.0% on a QoQ basis from $10000.0 in Q4 2025.

Oramed Pharmaceuticals (ORMP) Deferred Taxes (2017 - 2026) Analysis & Trends

Oramed Pharmaceuticals (ORMP) has 5 years of Deferred Taxes data on file, last reported at -$9.8 million in Q1 2026.

Quarterly Deferred Taxes changed N/A year-over-year to -$9.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.2 million (changed N/A YoY) and the FY2025 annual result came in at -$7.9 million, changed N/A from the prior year.
Deferred Taxes fell to -$9.8 million in Q1 2026, from $10000.0 in the prior quarter.
In the past five years, Deferred Taxes ranged from a high of $10000.0 in Q4 2025 to a low of -$9.8 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-69.70 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	194.40 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	2.66 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-
10	Oramed Pharmaceuticals	196.17 Mn	196.17 Mn	-	21.80 Mn

Download Data